Skip to main content
. 2017 Sep-Oct;43(5):380–392. doi: 10.1590/S1806-37562017000000219

Table 5. Rapid tuberculosis test prices, as reported by the molecular assay users surveyed, stratified by use of the Xpert assay and other molecular assays.a.

Price range (US$) Total Income level of the countries (World Bank classification)
High Upper middle Lower middle Low
Molecular assay use Molecular assay use Molecular assay use Molecular assay use Molecular assay use
Xpert Other Xpert Other Xpert Other Xpert Other Xpert Other
1-10 40 (26.32) 24 (15.29) 5 (12.20) 4 (7.55) 6 (13.33) 8 (13.56) 18 (43.90) 10 (27.03) 11 (44.00) 2 (25.00)
11-20 54 (35.53) 45 (28.66) 7 (17.07) 7 (13.21) 17 (37.78) 17 (28.81) 19 (46.34) 17 (45.95) 11 (44.00) 4 (50.00)
20-30 17 (11.18) 21 (13.38) 10 (24.39) 9 (16.98) 5 (11.11) 8 (13.56) 1 (2.44) 4 (10.81) 1 (4.00) 0 (0.00)
30-50 12 (7.89) 28 (17.83) 6 (14.63) 14 (26.42) 4 (8.89) 10 (16.95) 0 (0.00) 3 (8.11) 2 (8.00) 1 (12.50)
> 50 29 (19.08) 39 (24.84) 13 (31.71) 19 (35.85) 13 (28.89) 16 (27.12) 3 (7.32) 3 (8.11) 0 (0.00) 1 (12.50)
Subtotal 152 157 41 53 45 59 41 37 25 8
p 0.0621 0.5569 0.7336 0.1354 0.3818
Do not know 40 (20.83) 64 (28.96) 12 (22.64) 39 (42.39) 10 (18.18) 17 (22.37) 9 (18.00) 3 (7.50) 9 (26.47) 5 (38.46)
Total 192 221 53 92 55 76 50 40 34 13

Xpert: rapid molecular assay for the identification of Mycobacterium tuberculosis and the detection of rifampin resistance. aValues expressed as n (%), except where otherwise indicated.